Machine learning-driven antiviral libraries targeting respiratory viruses
Preprint
- 4 February 2025
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
Viral infections represent a significant global health concern; therefore, herein we seek to design compound libraries with prospective antiviral activity. Viral diseases can range from mild symptoms to life-threatening conditions, and the impact of these infections has grown due to increased contagious rates driven by globalization. A prime example is the SARS-CoV-2 pandemic, which emphasized the urgent need to design and develop new antiviral drugs. This study aimed to generate a curated data set of compounds relevant to respiratory infections, focusing on predicting their antiviral activity. Specifically, the study leverages ML classification models to evaluate focused and on-demand compound libraries targeting pathways associated with viral respiratory infections. ML models were trained based on the antiviral biological activity related to respiratory diseases deposited on a major public compound database annotated with biological activity. The models were validated and retrained to classify and design antiviral-focused libraries on seven respiratory targets.Keywords
All Related Versions
- Version 1, 2025-02-04, ChemRxiv
- Published version: Digital Discovery, 4 (5), 1239.
This publication has 44 references indexed in Scilit:
- Rethinking the 'best method' paradigm: The effectiveness of hybrid and multidisciplinary approaches in chemoinformaticsArtificial Intelligence in the Life Sciences, 2024
- Keeping pace with the explosive growth of chemical libraries with structure‐based virtual screeningWIREs Computational Molecular Science, 2023
- Viral proteases as therapeutic targetsMolecular Aspects of Medicine, 2022
- Recent studies of nitrogen containing heterocyclic compounds as novel antiviral agents: A reviewBioorganic Chemistry, 2021
- Drug repurposing in COVID-19: A review with past, present and futureMetabolism Open, 2021
- Recent advances in the detection of respiratory virus infection in humansJournal of Medical Virology, 2020
- Adenine: an important drug scaffold for the design of antiviral agentsActa Pharmaceutica Sinica B, 2015
- Potential Application of Marine Algae as Antiviral Agents in Medicinal Foods2011
- Antiviral Drug Resistance: Mechanisms and Clinical ImplicationsInfectious Disease Clinics of North America, 2010
- The Economic Burden of Non–Influenza-Related Viral Respiratory Tract Infection in the United StatesArchives of internal medicine (1960), 2003